Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022 -- EDAP TMS…
- First clinical combination study of BBP-398 and LUMAKRAS set to evaluate safety and preliminary efficacy in solid tumors with…
With the addition of psilocybin and MDMA to Health Canada’s Special Access Program, Mydecine looks to offer a package of…
SOUTH ORANGE, NJ, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology…
Headset data confirms Auxly almost doubled overall market share, ending the year as the #5 LP in Canada and continues…
TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a…
CINCINNATI, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based…
LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell…
Congenica Expands its Clinical Consulting Services Cambridge, United Kingdom – 13 January 2022 - Congenica, the digital health company enabling…
Helsinn Launches Fully Integrated Targeted Therapy (FITT) Strategy and Announces Leadership and Structural Changes Strategy focuses on developing and commercializing…